Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Qing-jun Liu, Hong-liang Shen, Jun Lin, Xiu-hong Xu, Zheng-guo Ji, Xiao Han, Dong-hao Shang & Pei-qian Yang. (2016) Synergistic roles of p53 and HIF1α in human renal cell carcinoma-cell apoptosis responding to the inhibition of mTOR and MDM2 signaling pathways. Drug Design, Development and Therapy 10, pages 745-755.
Read now
Read now
Sergey V Karakashev & Mauricio J Reginato. (2015) Progress toward overcoming hypoxia-induced resistance to solid tumor therapy. Cancer Management and Research 7, pages 253-264.
Read now
Read now
Articles from other publishers (30)
R. G. Goncharov & M. G. Sharapov. (2023) Ischemia–Reperfusion Injury: Molecular Mechanisms of Pathogenesis and Methods of Their Correction. Molecular Biology 57:6, pages 1143-1164.
Crossref
Crossref
Jingying Cao, Renxian Cao, Yiqi Liu & Tao Dai. (2023) CPNE1 mediates glycolysis and metastasis of breast cancer through activation of PI3K/AKT/HIF-1α signaling. Pathology - Research and Practice 248, pages 154634.
Crossref
Crossref
Matthew Moghaddam, Silvia Vivarelli, Luca Falzone, Massimo Libra & Benjamin Bonavida. (2023) Cancer resistance via the downregulation of the tumor suppressors RKIP and PTEN expressions: therapeutic implications. Exploration of Targeted Anti-tumor Therapy, pages 170-207.
Crossref
Crossref
Mohamed M. Elseweidy, Sousou I. Ali, Mohamed A. Shaheen, Asmaa M. Abdelghafour & Sally K. Hammad. (2023)
Vanillin and pentoxifylline ameliorate isoproterenol-induced myocardial injury in rats
via
the Akt/HIF-1α/VEGF signaling pathway
. Food & Function 14:7, pages 3067-3082.
Crossref
Crossref
Axiang Li, Zizhen Liu, Tahir Ali, Ruyan Gao, Yanhua Luo, Qichao Gong, Chenyou Zheng, Weifen Li, Hongling Guo, Xinshe Liu, Shupeng Li & Tao Li. (2023) Roxadustat (FG-4592) abated lipopolysaccharides-induced depressive-like symptoms via PI3K signaling. Frontiers in Molecular Neuroscience 16.
Crossref
Crossref
Jie Liu, Xiaochun Hu, Lei Feng, Yun Lin, Shujing Liang, Zhounan Zhu, Shuo Shi & Chunyan Dong. (2022) Carbonic anhydrase IX-targeted H-APBC nanosystem combined with phototherapy facilitates the efficacy of PI3K/mTOR inhibitor and resists HIF-1α-dependent tumor hypoxia adaptation. Journal of Nanobiotechnology 20:1.
Crossref
Crossref
Carmel Mothersill, Alan Cocchetto & Colin Seymour. (2022) Low Dose and Non-Targeted Radiation Effects in Environmental Protection and Medicine—A New Model Focusing on Electromagnetic Signaling. International Journal of Molecular Sciences 23:19, pages 11118.
Crossref
Crossref
Weidong Cao, Qiang Zhou, Hongwei Wang, Wei Rao, Gang Cheng, Peng Wang, Shengli Guo, Bin Ren & Jianning Zhang. (2022) Hypoxia Promotes Glioma Stem Cell Proliferation by Enhancing the 14-3-3β Expression via the PI3K Pathway. Journal of Immunology Research 2022, pages 1-11.
Crossref
Crossref
Islamy Rahma Hutami, Takashi Izawa, Tsendsuren Khurel-Ochir, Takuma Sakamaki, Akihiko Iwasa & Eiji Tanaka. (2021) Macrophage Motility in Wound Healing Is Regulated by HIF-1α via S1P Signaling. International Journal of Molecular Sciences 22:16, pages 8992.
Crossref
Crossref
Ming-Huei Chou, Hui-Ching Chuang, Yu-Tsai Lin, Ming-Hsien Tsai, Ying-Hsien Kao, I-Chun Lin, Tai-Lin Huang, Fu-Min Fang & Chih-Yen Chien. (2021) Targeting mTOR-CCL20 Signaling May Improve Response to Docetaxel in Head and Neck Squamous Cell Carcinoma. International Journal of Molecular Sciences 22:6, pages 3046.
Crossref
Crossref
Areumnuri Kim, Sehwan Shim, Young-heon Kim, Min-Jung Kim, Sunhoo Park & Jae Kyung Myung. (2020) Inhibition of Y Box Binding Protein 1 Suppresses Cell Growth and Motility in Colorectal Cancer. Molecular Cancer Therapeutics 19:2, pages 479-489.
Crossref
Crossref
Tanmoy Paul & Sharmita Basu. (2020) Vascular onco-therapies targeting continuous and intermittent intra-tumor hypoxia. Journal of Cancer Research and Practice 7:3, pages 105.
Crossref
Crossref
Gregg L. Semenza. (2019) Pharmacologic Targeting of Hypoxia-Inducible Factors. Annual Review of Pharmacology and Toxicology 59:1, pages 379-403.
Crossref
Crossref
Zhen Zhang, Li Yao, Jinhua Yang, Zhenkang Wang & Gang Du. (2018) PI3K/Akt and HIF‑1 signaling pathway in hypoxia‑ischemia (Review). Molecular Medicine Reports.
Crossref
Crossref
Melissa A. Hoffman, Bin Fang, Eric B. Haura, Uwe Rix & John M. Koomen. (2017) Comparison of Quantitative Mass Spectrometry Platforms for Monitoring Kinase ATP Probe Uptake in Lung Cancer. Journal of Proteome Research 17:1, pages 63-75.
Crossref
Crossref
Niccolò Bartalucci, Laura Calabresi, Manjola Balliu, Serena Martinelli, Maria Caterina Rossi, Jean Luc Villeval, Francesco Annunziato, Paola Guglielmelli & Alessandro M. Vannucchi. (2017)
Inhibitors of the PI3K/mTOR pathway prevent STAT5 phosphorylation in
JAK2V617F
mutated cells through PP2A/CIP2A axis
. Oncotarget 8:57, pages 96710-96724.
Crossref
Crossref
Jae-Young Kim & Joo-Yong Lee. (2017) Targeting Tumor Adaption to Chronic Hypoxia: Implications for Drug Resistance, and How It Can Be Overcome. International Journal of Molecular Sciences 18:9, pages 1854.
Crossref
Crossref
Samira Torki, Amin Soltani, Hedayatollah Shirzad, Nafiseh Esmaeil & Mahdi Ghatrehsamani. (2017) Synergistic antitumor effect of NVP-BEZ235 and CAPE on MDA-MB-231 breast cancer cells. Biomedicine & Pharmacotherapy 92, pages 39-45.
Crossref
Crossref
Morteza Eskandani, Somayeh Vandghanooni, Jaleh Barar, Hossein Nazemiyeh & Yadollah Omidi. (2017) Cell physiology regulation by hypoxia inducible factor-1: Targeting oxygen-related nanomachineries of hypoxic cells. International Journal of Biological Macromolecules 99, pages 46-62.
Crossref
Crossref
Anthony R. Martin, Cyril Ronco, Luc Demange & Rachid Benhida. (2017) Hypoxia inducible factor down-regulation, cancer and cancer stem cells (CSCs): ongoing success stories. MedChemComm 8:1, pages 21-52.
Crossref
Crossref
Kuiqing Li, Xu Chen, Cheng Liu, Peng Gu, Zhuohang Li, Shaoxu Wu, Kewei Xu, Tianxin Lin & Jian Huang. (2015) Pirarubicin induces an autophagic cytoprotective response through suppression of the mammalian target of rapamycin signaling pathway in human bladder cancer cells. Biochemical and Biophysical Research Communications 460:2, pages 380-385.
Crossref
Crossref
Garrick K. Wilson, Daniel A. Tennant & Jane A. McKeating. (2014) Hypoxia inducible factors in liver disease and hepatocellular carcinoma: Current understanding and future directions. Journal of Hepatology 61:6, pages 1397-1406.
Crossref
Crossref
CAMILLA EVANGELISTI, CECILIA EVANGELISTI, FRANCESCA CHIARINI, ANNALISA LONETTI, FRANCESCA BUONTEMPO, DANIELA BRESSANIN, ALESSANDRA CAPPELLINI, ESTER ORSINI, JAMES A. McCUBREY & ALBERTO M. MARTELLI. (2014) Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia (Review). International Journal of Oncology 45:3, pages 909-918.
Crossref
Crossref
Fei Wang, Wei Zhang, Liting Guo, Wen Bao, Nan Jin, Ran Liu, Ping Liu, Yonghui Wang, Qinglong Guo & Baoan Chen. (2014) Gambogic acid suppresses hypoxia‐induced hypoxia‐inducible factor‐1α/vascular endothelial growth factor expression via inhibiting phosphatidylinositol 3‐kinase/Akt/mammalian target protein of rapamycin pathway in multiple myeloma cells. Cancer Science 105:8, pages 1063-1070.
Crossref
Crossref
Jason Brocato, Yana Chervona & Max Costa. (2014)
Molecular Responses to Hypoxia-Inducible Factor 1
α
and Beyond
. Molecular Pharmacology 85:5, pages 651-657.
Crossref
Crossref
Stephan Kruck, Axel S. Merseburger, Arnulf Stenzl & Jens Bedke. (2013) How far is the horizon? From current targets to future drugs in advanced renal cancer. World Journal of Urology 32:1, pages 69-77.
Crossref
Crossref
Sebastian KugerEmre CörekBülent PolatUlrike KämmererMichael FlentjeCholpon S. Djuzenova. (2014) Novel PI3K and mTOR Inhibitor NVP-BEZ235 Radiosensitizes Breast Cancer Cell Lines under Normoxic and Hypoxic Conditions. Breast Cancer: Basic and Clinical Research 8, pages BCBCR.S13693.
Crossref
Crossref
Wei-Dong Cao, Nobuyuki Kawai, Keisuke Miyake, Xiang Zhang, Zhou Fei & Takashi Tamiya. (2013) Relationship of 14-3-3zeta (ζ), HIF-1α, and VEGF expression in human brain gliomas. Brain Tumor Pathology 31:1, pages 1-10.
Crossref
Crossref
Jian-ri Li, Chen-Li Cheng, Chi-Rei Yang, Yen-Chuan Ou, Ming-Ju Wu & Jiunn-Liang Ko. (2013) Dual inhibitor of phosphoinositide 3-kinase/mammalian target of rapamycin NVP-BEZ235 effectively inhibits cisplatin-resistant urothelial cancer cell growth through autophagic flux. Toxicology Letters 220:3, pages 267-276.
Crossref
Crossref
Feng-Ze Wang, Peng-Jiao, Na-Na Yang, Chuang-Yuan, Ya-Li Zhao, Qiang-Qiang Liu, Hong-Rong Fei & Ji-Guo Zhang. (2013) PF-04691502 triggers cell cycle arrest, apoptosis and inhibits the angiogenesis in hepatocellular carcinoma cells. Toxicology Letters 220:2, pages 150-156.
Crossref
Crossref